中外製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/06/15 | 4,115 | 4,170 | 4,110 | 4,125 | +10 | +0.2% | 927,700 |
2017/06/14 | 4,140 | 4,160 | 4,110 | 4,115 | -40 | -1% | 852,500 |
2017/06/13 | 4,120 | 4,170 | 4,120 | 4,155 | +10 | +0.2% | 601,000 |
2017/06/12 | 4,105 | 4,160 | 4,090 | 4,145 | +30 | +0.7% | 736,000 |
2017/06/09 | 4,185 | 4,220 | 4,090 | 4,115 | -55 | -1.3% | 1,820,600 |
2017/06/08 | 4,190 | 4,195 | 4,155 | 4,170 | -15 | -0.4% | 894,100 |
2017/06/07 | 4,200 | 4,235 | 4,170 | 4,185 | -25 | -0.6% | 842,600 |
2017/06/06 | 4,310 | 4,315 | 4,200 | 4,210 | -155 | -3.6% | 1,290,300 |
2017/06/05 | 4,330 | 4,390 | 4,290 | 4,365 | +15 | +0.3% | 826,900 |
2017/06/02 | 4,360 | 4,380 | 4,295 | 4,350 | +5 | +0.1% | 1,223,500 |
2017/06/01 | 4,245 | 4,345 | 4,240 | 4,345 | +135 | +3.2% | 1,105,300 |
2017/05/31 | 4,185 | 4,235 | 4,185 | 4,210 | +10 | +0.2% | 1,228,400 |
2017/05/30 | 4,210 | 4,220 | 4,185 | 4,200 | -5 | -0.1% | 441,800 |
2017/05/29 | 4,210 | 4,225 | 4,185 | 4,205 | -5 | -0.1% | 840,500 |
2017/05/26 | 4,210 | 4,235 | 4,200 | 4,210 | -25 | -0.6% | 576,600 |
2017/05/25 | 4,225 | 4,240 | 4,190 | 4,235 | +10 | +0.2% | 564,600 |
2017/05/24 | 4,250 | 4,250 | 4,205 | 4,225 | ±0 | ±0% | 610,400 |
2017/05/23 | 4,205 | 4,250 | 4,205 | 4,225 | ±0 | ±0% | 421,900 |
2017/05/22 | 4,205 | 4,235 | 4,200 | 4,225 | +10 | +0.2% | 447,000 |
2017/05/19 | 4,215 | 4,240 | 4,205 | 4,215 | -30 | -0.7% | 813,400 |
2017/05/18 | 4,215 | 4,270 | 4,195 | 4,245 | ±0 | ±0% | 809,100 |
2017/05/17 | 4,195 | 4,255 | 4,195 | 4,245 | +25 | +0.6% | 994,400 |
2017/05/16 | 4,175 | 4,230 | 4,160 | 4,220 | +50 | +1.2% | 848,200 |
2017/05/15 | 4,095 | 4,190 | 4,090 | 4,170 | +55 | +1.3% | 1,133,100 |
2017/05/12 | 4,115 | 4,140 | 4,070 | 4,115 | +15 | +0.4% | 1,212,900 |
2017/05/11 | 4,110 | 4,120 | 4,065 | 4,100 | -35 | -0.8% | 885,500 |
2017/05/10 | 4,135 | 4,165 | 4,110 | 4,135 | ±0 | ±0% | 703,200 |
2017/05/09 | 4,125 | 4,165 | 4,110 | 4,135 | +25 | +0.6% | 943,200 |
2017/05/08 | 4,050 | 4,125 | 4,045 | 4,110 | +95 | +2.4% | 1,177,300 |
2017/05/02 | 4,000 | 4,020 | 3,980 | 4,015 | +20 | +0.5% | 998,700 |
2017/05/01 | 3,975 | 3,995 | 3,950 | 3,995 | +45 | +1.1% | 646,400 |
2017/04/28 | 3,950 | 3,975 | 3,925 | 3,950 | ±0 | ±0% | 680,900 |
2017/04/27 | 3,965 | 3,980 | 3,940 | 3,950 | +5 | +0.1% | 780,600 |
2017/04/26 | 3,975 | 4,040 | 3,895 | 3,945 | +70 | +1.8% | 1,655,700 |
2017/04/25 | 3,935 | 3,935 | 3,855 | 3,875 | -35 | -0.9% | 929,000 |
2017/04/24 | 3,920 | 3,935 | 3,895 | 3,910 | +45 | +1.2% | 851,600 |
2017/04/21 | 3,825 | 3,880 | 3,825 | 3,865 | +50 | +1.3% | 878,600 |
2017/04/20 | 3,845 | 3,855 | 3,805 | 3,815 | -30 | -0.8% | 766,200 |
2017/04/19 | 3,835 | 3,930 | 3,835 | 3,845 | -30 | -0.8% | 830,200 |
2017/04/18 | 3,835 | 3,885 | 3,820 | 3,875 | +55 | +1.4% | 860,800 |
2017/04/17 | 3,740 | 3,830 | 3,735 | 3,820 | +55 | +1.5% | 565,000 |
2017/04/14 | 3,850 | 3,850 | 3,750 | 3,765 | -15 | -0.4% | 1,597,800 |
2017/04/13 | 3,780 | 3,805 | 3,770 | 3,780 | -30 | -0.8% | 711,000 |
2017/04/12 | 3,785 | 3,815 | 3,780 | 3,810 | -15 | -0.4% | 1,110,400 |
2017/04/11 | 3,810 | 3,855 | 3,785 | 3,825 | -15 | -0.4% | 891,500 |
2017/04/10 | 3,880 | 3,890 | 3,825 | 3,840 | -15 | -0.4% | 711,900 |
2017/04/07 | 3,830 | 3,880 | 3,810 | 3,855 | +30 | +0.8% | 1,080,700 |
2017/04/06 | 3,905 | 3,905 | 3,805 | 3,825 | -70 | -1.8% | 1,159,800 |
2017/04/05 | 3,935 | 3,955 | 3,875 | 3,895 | -45 | -1.1% | 856,500 |
2017/04/04 | 3,915 | 3,980 | 3,910 | 3,940 | +90 | +2.3% | 2,112,200 |
2001~
2050
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
中外薬 | 627,000円 | +1.7% | +5.0% | 3.99% | 25.17倍 | 5.20倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
武 田 | 458,900円 | -1.1% | +75.3% | 4.36% | 31.79倍 | 1.05倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
第一三共 | 370,000円 | +6.0% | +4.0% | 2.11% | 22.83倍 | 4.22倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
大塚HD | 806,600円 | +2.2% | +28.0% | 1.74% | 12.91倍 | 1.56倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 169,200円 | +0.9% | +380.2% | 4.61% | 23.31倍 | 2.00倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム